Hot Features
Pharma-Bio Serv, Inc. operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company offers a broad range of technical compliance consulting services, including regulatory affairs, qual... Pharma-Bio Serv, Inc. operates as a regulatory affair, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company offers a broad range of technical compliance consulting services, including regulatory affairs, quality assurance, compliance, technology transfer, validation, engineering, project management, and process support. It serves pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0354 | -6.73772363913 | 0.5254 | 0.565 | 0.49 | 1513 | 0.50199504 | CS |
| 4 | -0.06 | -10.9090909091 | 0.55 | 0.58 | 0.49 | 1448 | 0.5399026 | CS |
| 12 | -0.05 | -9.25925925926 | 0.54 | 0.5845 | 0.475 | 2734 | 0.51717867 | CS |
| 26 | -0.069 | -12.343470483 | 0.559 | 0.6 | 0.4336 | 5354 | 0.54059644 | CS |
| 52 | -0.01 | -2 | 0.5 | 1.36 | 0.4336 | 7269 | 0.57921298 | CS |
| 156 | -0.41 | -45.5555555556 | 0.9 | 1.36 | 0.3127 | 5704 | 0.66726958 | CS |
| 260 | -0.79 | -61.71875 | 1.28 | 1.36 | 0.3127 | 6479 | 0.8202758 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.